Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
6.79
+0.68 (11.13%)
At close: Dec 5, 2025, 4:00 PM EST
6.81
+0.02 (0.29%)
After-hours: Dec 5, 2025, 7:44 PM EST
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $4.05 million as of December 5, 2025. Its market cap has increased by 15.47% in one year.
Market Cap
4.05M
Enterprise Value
295.89K
1-Year Change
15.47%
Ranking
Category
Stock Price
$6.79
Market Cap Chart
Since December 31, 2020, Enveric Biosciences's market cap has decreased from $135.21B to $4.05M, a decrease of -100.00%. That is a compound annual growth rate of -87.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 3.65M | 0.07% |
| Dec 31, 2024 | 3.64M | 20.78% |
| Dec 29, 2023 | 3.02M | -30.19% |
| Dec 30, 2022 | 4.32M | -85.19% |
| Dec 31, 2021 | 29.19M | -99.98% |
| Dec 31, 2020 | 135.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.68B |
| Johnson & Johnson | 494.92B |
| AbbVie | 396.55B |
| UnitedHealth Group | 293.98B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 250.76B |
| Abbott Laboratories | 219.65B |